Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from MedX Health ( (TSE:MDX) ) is now available.
MedX Health Corp. has announced the initial closing of its non-brokered private placement, raising $527,500 through the issuance of 7,033,000 units to accredited investors. The company plans to use the funds to further develop its SIAscopy® on DermSecure® telemedicine platform and expand into the occupational health market. The placement, which aims to raise a maximum of $2.5 million, has been extended to November 7, 2025, following conditional acceptance from the TSX-V. This move is expected to enhance MedX’s market positioning by supporting the launch of its advanced telemedicine technology.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, specializes in non-invasive skin assessment and teledermatology. The company offers the SIAscopy® technology integrated into the DermSecure® platform, which provides pain-free and accurate imaging of skin lesions for rapid dermatologist review. MedX’s products are approved for use in 38 territories worldwide, including Canada, the U.S., Australia, New Zealand, the UK, the EU, and Turkey.
Average Trading Volume: 150,457
Technical Sentiment Signal: Sell
Current Market Cap: C$19.62M
For detailed information about MDX stock, go to TipRanks’ Stock Analysis page.